Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd (SHA:688336)
China flag China · Delayed Price · Currency is CNY
32.37
-0.13 (-0.40%)
Oct 23, 2026, 11:30 AM CST

SHA:688336 Cash Flow Statement

Millions CNY. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
3,0882,899704.58294.6149.318.06
Depreciation & Amortization
123.28123.47127.9796.08122.41135.46
Other Amortization
0.540.36----
Loss (Gain) From Sale of Assets
1.091.09-0.12-56.390.9412.98
Loss (Gain) From Sale of Investments
-99.77-99.77-411.59-3-19.98-20.93
Stock-Based Compensation
26.4626.466.97-6.282.5411.42
Provision & Write-off of Bad Debts
-0.26-0.26-0.23-6.795.491.22
Other Operating Activities
-3,102-74.03-77.49-35.913.68-20.61
Change in Accounts Receivable
23.7823.78-60.9315.4107.1-258.94
Change in Inventory
-30.46-30.46-35.0133.36--
Change in Accounts Payable
186.34186.3417.8363.469.24-67.49
Change in Unearned Revenue
-15.64-15.64-7.09-5.46-10.49-18.83
Operating Cash Flow
203.953,043281.14416.35233.49-243.79
Operating Cash Flow Growth
-93.00%982.55%-32.48%78.32%--

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Capital Expenditures
-276-252.95-280.78-235.75-221.26-263.82
Sale of Property, Plant & Equipment
0.02-0.69100.450.40.38
Investment in Securities
47.85-3,058-953.98-366.5-725.89214
Other Investing Activities
252.65147.07483.9322.3730.0630.94
Investing Cash Flow
24.53-3,164-750.14-479.42-916.69-18.5

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Short-Term Debt Issued
--5050150-
Total Debt Issued
--5050150-
Short-Term Debt Repaid
--50-50-150--
Total Debt Repaid
--50-50-150--
Net Debt Issued (Repaid)
--50--100150-
Issuance of Common Stock
15.6415.39--2.3-
Common Dividends Paid
-298.49-76.46-52.37-1.47-1.22-
Financing Cash Flow
-282.86-111.07-52.37-101.47151.08-

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Foreign Exchange Rate Adjustments
0.534.670.282.271.47-0.17
Net Cash Flow
-53.85-226.53-521.1-162.27-530.66-262.47

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
-72.052,7910.35180.6112.23-507.61
Free Cash Flow Growth
-787511.40%-99.80%1376.67%--
Free Cash Flow Margin
-1.61%66.45%0.03%17.81%1.48%-54.65%
Free Cash Flow Per Share
-0.083.11-0.200.01-0.58
Levered Free Cash Flow
-1,8211,979-66.6346.51-14.48-394.76
Unlevered Free Cash Flow
-1,8211,979-65.947.38-13.66-394.76

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash Income Tax Paid
416.8844.2643.129.2424.5721.75
Change in Working Capital
166.83166.83-68.94134.0369.1-381.39